Little is known about the impact of antiviral treatments on biomarkers of COVID-19 severity. Here, we measured biomarkers during the course of COVID-19 in high-risk non-hospitalized patients treated with or without the antiviral remdesivir.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us